11 Jul 2022
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
Author: admintech | Filed under: Press ReleaseAgreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md., July 11, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing…